ALOX5AP and ocular hypertension: The results demonstrate that Alox5AP (5-lipoxygenase activating protein, FLAP), which is a cofactor required for full 5-LOX enzymatic activity, was significantly upregulated at 2 and 4 weeks, while there was no change in the levels of Alox5 in response to ocular hypertension.